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Abstract
Background: Insulin action on protein synthesis (translation of transcripts) and post-translational modifications, especially of
those involving the reversible modifications such as phosphorylation of various signaling proteins, are extensively studied
but insulin effect on transcription of genes, especially of transcriptional temporal patterns remains to be fully defined.
Methodology/Principal Findings: To identify significant transcriptional temporal patterns we utilized primary differentiated
rat skeletal muscle myotubes which were treated with insulin and samples were collected every 20 min for 8 hours. Pooled
samples at every hour were analyzed by gene array approach to measure transcript levels. The patterns of transcript levels
were analyzed based on a novel method that integrates selection, clustering, and functional annotation to find the main
temporal patterns associated to functional groups of differentially expressed genes. 326 genes were found to be
differentially expressed in response to in vitro insulin administration in skeletal muscle myotubes. Approximately 20% of the
genes that were differentially expressed were identified as belonging to the insulin signaling pathway. Characteristic
transcriptional temporal patterns include: (a) a slow and gradual decrease in gene expression, (b) a gradual increase in gene
expression reaching a peak at about 5 hours and then reaching a plateau or an initial decrease and other different variable
pattern of increase in gene expression over time.
Conclusion/Significance: The new method allows identifying characteristic dynamic responses to insulin stimulus, common
to a number of genes and associated to the same functional group. The results demonstrate that insulin treatment elicited
different clusters of gene transcript profile supporting a temporal regulation of gene expression by insulin in skeletal muscle
cells.
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Introduction
Skeletal muscle is responsible for about 65% of glucose disposal
following a meal [1] and reduced insulin induced glucose disposal
results in impaired glucose tolerance. In vivo, insulin plays an
important role in the regulation of skeletal muscle glucose uptake
and regulation of skeletal muscle protein, amino acid and fatty
acid metabolism [2,3]. Acutely, insulin stimulates glucose uptake
in skeletal muscle cells by accelerating the recruitment of GLUT4
to the sarcolemma [4–7], a process that is exquisitely regulated by
a specific insulin-responsive protein signaling cascade (i.e., IR/
IRS1/PI3K/Akt) [4,5,8,9]. Similarly, insulin acutely stimulates
protein synthesis (in the presence of adequate amino acids) by also
activating a specific insulin-responsive protein signaling cascade
(i.e., Akt/mTOR/S6K) [10–14]. Both of these responses are
regulated by reversible post-translational modifications (i.e.,
phosphorylation) of key signaling protein molecules. However,
less information is available about insulin impact on gene
transcription that also may affect insulin action: it is currently
unknown whether insulin acutely enhances transcription of genes
or whether there is a time related pattern in transcribing the genes
thereby having a different level of regulation of insulin action on
gene expression. A better understanding of the impact of insulin
on transcript levels of various genes is critical to acquire a more
thorough understanding on how insulin exerts its pleiotropic
effects on skeletal muscle glucose uptake as well as protein
synthesis.
The microarray technology has been extensively used to identify
differentially expressed genes in skeletal muscle cells under
different physiological states, e.g., non-diabetic vs. diabetic subjects
during poor glycemic control and following insulin treatment [15],
insulin treated versus insulin deprived type 1 diabetic patients [16],
and [15], normal vs. impaired glucose tolerant individuals [17],
and basal state vs. euglycemic hyperinsulinemic clamp [18].
Further information on transcriptional regulation can be gained by
monitoring gene transcripts related to time following insulin
administration. In fact, in pre/post stimulus studies in which the
transcriptional response is monitored at one specific time instant
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after a prolonged insulin exposure, genes showing a transient
response followed by a return to the pre-stimulus expression or a
systematic, but small in magnitude, change in the expression, are
likely to be missed. In contrast, monitoring the dynamic response
allows identifying transient responses, which might be character-
istic, and, if common to a number of genes associated to the same
functional group, might give insight into the function or functions
performed by the gene circuitry. The aim of the present work is to
exploit the potential of a dynamic study to investigate the
transcriptional response of skeletal muscle cells during acute
insulin stimulation. To this purpose, we designed and conducted
the present gene-array experiment in differentiated L6 myotubes.
To identify significant transcriptional temporal patterns in
muscle cells treated with insulin and to characterize them from a
functional point of view, here we propose a new analytical
method applied to experimental data. This method aims at
overcoming some drawbacks of the conventional analysis
approach based on selection of differentially expressed genes,
clustering and functional annotation based on Gene Ontology
(GO) [19]. The new approach that we apply in the current study
1) improves selection of differentially expressed genes by
diminishing the number of false negatives while maintaining
constant the false discovery rate, i.e. the number of false positives
divided by the number of selected genes; 2) clusters genes with the
same transcriptional pattern without requiring the user to fix the
number of clusters and 3) automatically annotates these clusters
with the most specific GO terms, avoiding redundancy of the
information.
Materials and Methods
Skeletal Muscle Culture
L6 skeletal muscle myoblasts (purchased from ATCC,
Manassas, VA) were grown and kept in low glucose (5 mM)
DMEM growth media supplemented with fetal bovine serum
(FBS) and an antibiotic antimycotic mixture (10% FBS, 4 mM L-
Glutamine, 1.0 mM sodium pyruvate, 100 ug/ml penicillin
100 ug/ml streptomycin). Four plates were prepared for each
pre-defined time sample at a density of 6:86105cells per 100 mm
dish and incubated overnight in DMEM growth media. On the
second day, the DMEM growth media was changed to DMEM
differentiation media with 1% FBS to initiate myotube
differentiation. The differentiation media was changed every 2
days. On sixth day differentiation was completed and medium
was changed to serum free DMEM for an 8 hour pre-incubation.
The culture was split into 2 different groups: insulin treated and
control. Just after the collection of the first biological sample at
time 09, for each time point the medium on one plate was
changed to serum free DMEM with 20 nM insulin, whereas one
plate was used as control (DMEM with 0 nM insulin). Cells were
harvested at the designated time points by decanting off
overlying medium, scraping the cells into cryovials and freezing
immediately in liquid nitrogen. Samples were collected at times
0, 20, 40, 60,…, 480 minutes (every 20 minutes, for 8 hours)
from both insulin treated and control cultures, for a total of 50
biological samples.
Samples (20–40–60), (80–100–120), (140,160,180), (200–220,
240), (260, 280, 300), (320,340,360) (380–400–420) and (440–460–
480) from insulin-treated and control culture were pooled
together, obtaining eight joint samples. Consistently, sample 09
was harvested and collected in triplicates and pooled together (0a–
0b–0c) for each culture and two targets for the hybridization were
prepared separately. The pooling step was chosen to achieve a
compromise between the cost of the experiment and the frequency
of the sampling grid: it is safer to average the signal by pooling the
biological samples than to use a sparse sampling grid (fast
regulated genes would be easily lost e.g. by collecting one sample
per hour).
All the culturing and sampling procedure described above was
repeated two additional times on different days, using the same
identical cell line, to obtain a complete triplicate of the experiment.
Measurements
Total RNAs were purified using an RNeasy Protect Mini Kit
from Qiagen. The quality and quantity of total RNA was
measured using the Agilent test on a Bioanalyzer (Agilent
Technologies, Palo Alto, CA). Gene transcript profiles in both
control and treated cultures were studied by high-density
oligonucleotide microarrays containing probes for 31,099 genes
and expressed sequence tags (Rat-230.2 GeneChip arrays;
Affymetrix, Santa Clara, CA), for a total of 54 chips. Sample
labeling, hybridization of test array, and hybridization of full-
size arrays were performed by the Mayo Clinic Advanced
Genomics Technology Center Microarray Lab using protocols
described in the Affymetrix GeneChip expression analysis
technical manual.
The data discussed in this publication are MIAME compliant and
have been deposited in NCBI’s Gene Expression Omnibus [20] and
are accessible through GEO Series accession number GSE28997
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28997).
Preprocessing
Image quantification was performed using GeneChip (Affyme-
trix, SantaClara, CA) scanner and software. Preprocessing steps
such as background subtraction, probe cell normalization and
expression level calculations, were performed using quantile
normalization and Robust Microarray Analysis (RMA) software
[21].
Genes were pre-filtered using Affymetrix Detection calls (genes
that were not present in at least one chip were filtered out). The
remaining 21958 probes were analyzed using the method
described in the following for the function-based discovery of
significant transcriptional temporal patterns.
Analysis of Significant Transcriptional Temporal Patterns
A new method is here proposed to identify significant
transcriptional temporal patterns, based on four different compu-
tational steps: 1) Gene Ranking, i.e. all genes are ranked according to
a false discovery rate p-value reflecting the likelihood that the gene
is differentially expressed; 2) Functional Gene Annotation based on
GO; 3) Search for the Temporal Patterns, i.e. each functional group is
searched for temporal patterns characterizing it; 4) Selection of
Differentially Expressed Genes, based on both the false discovery rate
(FDR) p-values and the characteristic patterns.
The output of the method is a set of clusters of differentially
expressed genes, each characterized by a specific temporal pattern
and by the most specific functional annotations. The four steps of
the methods are described in what follows.
Gene Ranking
Genes are ranked according to FDR p-values using a selection
method of choice. In the case of the data analysis performed in this
work, we used a method previously proposed [22] that calculates
the area of the region bounded by the time series expression profile
and assigns a p-value to the gene according to this area and a null
hypothesis distribution, based on a model of the experimental
error, to be derived from experimental replicates. The two
Transcriptional Patterns in Insulin Signaling
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replicates available at time zero were used to derive the
experimental error distribution at different intensity expression
values and, consequently, the null hypothesis distribution of the
area bounded by the treated-minus-control expression profile.
Functional Gene Annotation
Gene Ontology annotation is used to define the biologically
relevant sets of genes. GO terms are organized in a directed
acyclic graph in which each node corresponds to a GO term and
may have multiple parents: nodes farther from the root correspond
to more specialized terms; nodes closer to the root to less
specialized terms, thus implying that genes annotated with a
specific node are also annotated with every ancestor of that node.
In the case of the data analysis performed in this work, we used
Molecular Function GO annotation. An additional set containing
159 genes involved in insulin signaling according to GenMapp
pathway [23] was also used.
Search for the Temporal Patterns
For each GO node, the algorithm searches the representative
temporal patterns characterizing the transcriptional response. In
particular, among the genes associated to a specific GO term, the
algorithm searches for a subset of genes whose time series
expression profile Xi =,xi(1), …, xi(m). can be modeled by the
following equation:
Xi~ki.Pzqiz
X
ð1Þ
where P=,p(1), …, p(m). is the characteristic temporal
expression pattern, i.e. a vector of m (number of time points)
expression values, ki and qi are the gene i specific parameters and
S encodes the measurement error variance. The algorithm
iteratively performs a gene-specific parameter identification step
and a temporal pattern search step. In the first step, the
parameters ki and qi are identified for each gene i, using weighted
least squares method. A goodness of fit test is performed for each
gene i and only genes with significant p-value are kept in the
cluster. In the second step, P is estimated at each sampling time,
using again weighted least squares, but considering as data the ki
and qi of the genes belonging to the cluster and estimated at the
previous step. All the n genes being analyzed go again through the
first step, so to identify new ki and qi and re-define the cluster
membership based on the newly estimated pattern P. All the
procedure is reiterated until the list of genes in the cluster does not
change or a maximum number of iterations is reached. Each
identified pattern is thus characterized by a cluster of genes with
correlated profiles and the same annotation.
For each discovered pattern, the set of genes fitting this pattern
(fitP) and the set of genes that do not fit it (—|fitP) are defined. Only
if significant, i.e. if it contains at least one gene with false discovery
rate p-value lower than a fixed threshold, e.g. 0.05, fitP is recorded
as a cluster in the GO node under analysis. The procedure is then
iteratively applied to —|fitP, until —|fitP contains no genes or no
significant patterns are discovered.
Nodes are analyzed starting from the leaves of the GO graph,
i.e. the nodes farthest from the root, which are the most specific
GO terms; whenever a significant pattern is identified, genes
correlated to the pattern are removed from all the ancestors of the
node, so to avoid redundancy and annotate genes with the most
specific available biological information, analogously to what has
been proposed in [24]. Conversely, genes correlated to a pattern
are not removed from the sibling nodes.
Further details about the method are given in (Methods S1).
Selection of Differentially Expressed Genes
Given the high number of genes and the lack of replicates that
usually characterize high-throughput studies, gene selection
procedure has low statistical power. Moreover, the need to control
the false positive rate in a multiple testing condition, e.g. by using
FDR, leads to very small significant level a thus increasing the
number of false negatives. To lower the percentage of false
negatives, we recover, among the gene not selected as differentially
expressed by a FDR threshold of 5%, those genes that: (a) have a
p-value (not corrected for multiple testing) lower than 5%; are
associated to a cluster of genes: i) sharing the same temporal
transcriptional profile; ii) all annotated with the same functional
term, iii) containing at least one gene with significant FDR
corrected p-value.
2) are associated with a gene cluster containing at least 1 gene
with significant FDR corrected p_value. As d above, membership
to a cluster is based, beside common functional annotation, on the
goodness of fit to the corresponding temporal pattern and it is
statistically assessed in comparison to a flat profile.
Intuitively, since a group of genes associated to a pattern
contains at least one gene with significant false discovery rate p-
value, all genes in the group significantly correlated to the same
temporal pattern, significantly different from a flat profile and
sharing the same functional annotation are likely to be
differentially expressed.
Simulated Data
100 data sets of 1000 genes monitored on 13 time samples were
simulated. Each data set consists of 120 differentially expressed
genes separated in 6 clusters characterized by different temporal
patterns (Figure 1) and 880 not differentially expressed profiles.
Patterns 1, 2 and 3 in Figure 1, vary between 21 and 1; whereas
patterns 4, 5 and 6 vary between 0 and 1. Differentially expressed
gene profiles were generated from the pre-defined patterns, using
the model described in Eq. (1): for each pattern 20 gene profiles
were generated: 10 with ki and qi sampled from uniform
distributions in the intervals 6(0.5, 2) and (20.5, 0.5), respectively,
and 10 with ki and qi sampled from uniform distribution in the
intervals 6(1, 3) and (23, 3), respectively. Gaussian noise was
added to all data with mean 0 and standard deviation equal to 0.2
(the range of expression of genes varies at maximum between 26
and 6).
Results
Method validation
The ability of the method to identify groups of genes belonging
to the same pattern was assessed on synthetic data by comparing
identified to simulated clusters, in terms of precision (number of
correctly classified genes among the inferred ones) and recall
(number of correctly classified genes among the true ones).
Figure 1 illustrates the characteristic patterns used to generate the
data (columns) and the results (rows) for one representative data set
among the 1000 simulated, containing 6 clusters of 20 genes each,
and 880 noisy expression profiles. The number of genes in the
intersection between a simulated and an identified cluster is
indicated; the maximum of these number for each simulated
cluster is assumed as the number of true positives, that is the
measure of the ability to identify clusters with all or most genes
belonging to a single (simulated) cluster. For each column,
precision is calculated as true positives divided by the number of
genes identified in the cluster; recall as true positives divided by the
number of genes in the simulated cluster. The average results on
the 100 simulated datasets are shown in Table 1.
Transcriptional Patterns in Insulin Signaling
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Since the method was applied in a pipeline with a selection
procedure, it is also of interest to assess its ability to select
differentially expressed genes. In average, on 100 simulations the
number of false negatives diminishes from 11% to 9% (p-
value = 0.0091, Wilcoxon test) in correspondence of a constant
false discovery rate (number of false positives divided by the
number of selected genes) of 5%. Therefore, the pattern search
applied in combination with the selection method, besides being
able to identify the main temporal patterns of expression, improves
the selection by lowering the percentage of the false negatives.
Transcriptional Temporal Patterns in Insulin Stimulated
Muscle Cells
326 genes were selected as differentially expressed and clustered
into 12 different clusters, each characterized by a specific expression
pattern. Figure 2 shows in red the average differential (treated
minus control) expression profiles of the genes in the different
clusters; the number of genes in each cluster and their differential
expression profile (in gray) is also reported. A detailed list of selected
genes, their annotation with the GO molecular function term and
the associated patterns is available in Table S1 (Tables S1.1,
S1.2, s1.3, S1.4, S1.5, S1.6, S1.7, S1.8, S1.9, S1.10, S1.11,
S1.12, S1.13). To obtain a more synthetic annotation, the GO
nodes directly connected by a path in the GO graph were grouped,
thus obtaining 13 GO groups plus the group of genes annotated to
insulin signaling. Each GO group, thus characterized by an isolated
sub-graph of siblings or ancestors terms, was labeled with the most
general of these terms. Genes can appear annotated in more than
one GO term and/or in more patterns since, as explained in
Method, a gene associated to a pattern and a GO term is deleted
from the ancestor of the GO node it belongs to, but not from its
siblings. Figure 3 shows, for each pattern, the percentage of genes
belonging to insulin signaling pathway (IS) and to each GO group
(G1–G13). GO enrichment analysis based on Fisher’s Exact Test
was also performed to highlight the most relevant GO terms
associated with the genes belonging to each pattern with respect to
the total number of selected genes. Enriched GO terms (p-
value,0.05) are highlighted with a star symbol in Figure 3.
104 genes annotated to GO nodes isolated in the GO tree, i.e.
without sibling or parent nodes found as significant after the
analysis, are not shown in Figure 3 and in
S1.3, S1.4, S1.5, S1.6, S1.7, S1.8, S1.9, S1.10, S1.11,
S1.12, S1.13; complete results and information on selected genes,
Table S2.
Genes belonging to patterns 1 and 4, which are also the most
numerous, are annotated to many different GO groups, of which
many are also significantly enriched. Patterns 5, 9, 10, 11 and 12, on
the opposite, are characterized by genes belonging to a single GO
group: nucleotide binding (G8) for pattern 5, RNA binding (G11)
for pattern 10 and insulin signaling (IS) for patterns 9, 11 and 12.
Patterns 2, 3, 6, 7 and 8 are in an intermediate situation, with genes
annotated to a number of GO groups ranging from 3 to 6.
Looking at the GO groups associated to a limited number of
patterns, we found that transmembrane transporter activity (G1) is
characterized by 2 genes belonging to pattern 1 and 2 to pattern 2;
protein serine/threonine kinase activity (G2) by 3 genes belonging
to pattern 1, 2 to pattern 4 and 2 to pattern 3, these latter with
kinase inhibitor activity; Cation transmembrane transporter
activity (G5) is characterized by 3 genes belonging to pattern 1,
and 2 to pattern 8. Oxidoreductase activity (G7) and GTPase
activity (G9) contains genes associated only to pattern 1.
Interestingly, 62 of the 326 selected genes belong to insulin
signaling pathway, defined according to GenMapp annotation.
They are shown in Figure 4 in red, together with the identifier of
their cluster. Most of them are associated with pathways showing
down-regulation in treated vs. control cultures such as pattern 1, 8
and 12. In details, 14 genes are associated with pattern 1, 1 with
pattern 2, 2 with pattern 3, 3 with pattern 4, 1 with pattern 5, 1
with pattern 6, 3 with pattern 7, 15 with pattern 8, 2 with pattern
9, 1 with pattern 10, 4 with pattern 11 and 15 with pattern 12.
Among these genes, glycogen synthase 1 (GYS1) had not a
significant false discovery rate p-value, but it was selected because
highly correlated with other 14 significant genes in cluster 12, all
belonging to insulin signaling node.
Table 1. Results of the clustering on simulated data.
Clusters: 1 2 3 4 5 6
Precision 98% 99% 91% 96% 97% 98%
(2%) (1%) (9%) (3%) (1%) (1%)
Recall 85% 86% 33% 49% 35% 85%
(8%) (8%) (14%) (11%) (13%) (7%)
Average precision and recall results on 100 simulated data sets; standard
deviation in parenthesis.
doi:10.1371/journal.pone.0032391.t001
Figure 1. Temporal patterns used to simulate the data
(columns) and identified by the method (rows) for a specific
simulated data set. 100 data sets of 1000 genes monitored on 13
time samples were simulated. Each data set, like the one shown in this
figure, consists of 120 differentially expressed genes separated in 6
clusters characterized by different temporal patterns and 880 not
differentially expressed profiles. The number of genes in the
intersection between a simulated and an identified cluster is indicated;
the maximum of these numbers for each simulated cluster is assumed
as the number of true positives. For each column, precision is calculated
as true positives divided by the number of genes identified in the
cluster; recall as true positives divided by the number of genes in the
simulated cluster.
doi:10.1371/journal.pone.0032391.g001
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Tables S1.1, S1.2,
gene ontology terms and differential expression data associated
to each pattern are available in
 
Discussion
In the current study we applied a gene array profiling approach
to the transcriptional response of skeletal muscle myotubes treated
with insulin, to identify the main temporal expression patterns
associated to functional groups of differentially expressed genes.
We chose skeletal muscle cell line for this study considering that
frequent sampling from human and animal studies are fraught
with many logistical problems including ethical issues. The results
from the current study knowing the critical time points at which
the transcriptional responses are altered by insulin will enable
planning of future in vivo studies to assess insulin’s effect on muscle
Figure 2. Expression profile of genes selected as differentially expressed clustered in groups of genes sharing the same temporal
patterns. The average differential expression profiles (treated minus control) of the genes in the different clusters is shown in red; the number of
genes in each cluster and their differential expression profile (in gray) is also reported for each cluster.
doi:10.1371/journal.pone.0032391.g002
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gene transcripts. A prior time course of insulin response in primary
human myotubes from type 2 diabetic and non-diabetic
individuals (0, 0.5, 1, 2, 4, 8, and 24 hours) by Hansen et al.
[25] demonstrated a time dependent transcriptional responses of
inflammatory and pro-angiogenic pathways in relationship to
glycogen synthesis. The authors identified 102 transcripts as
differentially expressed in response to insulin some of which were
similar to those among the 326 gene transcripts that were
differentially expressed in our analysis. For example, the
angiogenic/anti-apoptotic gene transcripts, VEGF, FOS, and
SRF, were up-regulated in both studies. Comparison of the above
study to the current study is difficult since different species and cell
types were used, different insulin concentrations (20 nM vs. 1 mM)
were used, and the statistical analysis and the objectives of the two
studies differ. The analysis in the current study aimed at
integrating selection, clustering and functional annotation to find
the main temporal patterns associated to functional groups of
differentially expressed genes.
Our method was applied using a previously proposed method
for gene selection [22], but different choices are possible, as long as
the selection method provides a list of p-values associated to the list
of analyzed genes. Analogously, Gene Ontology functional
annotation or different annotation databases can be used. If the
functional annotation is hierarchical, it has to be codified in a
hierarchical direct graph as in the case of GO, before the search of
temporal patterns is performed. To associate patterns to the most
specific Gene Ontology nodes and avoid redundancy of the
information, our method starts searching patterns from the leaves
of the GO graph (i.e. the nodes farthest from the root, which are
the most specific) and whenever a significant pattern is identified,
genes correlated to the pattern are removed from all the ancestors
of the node. The pattern search is based on a linear model whose
parameters are identified using least squares, thus it accounts for
the error measurement, does not require the user to fix the
number of clusters and is not computationally demanding. Our
method improves the selection procedure by combining informa-
tion on false discovery rate p-value with both functional group and
characteristic temporal pattern association, thus diminishing the
number of false negatives without significantly increasing the
number of false positives. Previous works have addressed the
integration of prior knowledge either in clustering algorithms [26–
28] or in selection procedures [29], whereas our approach
integrates selection, clustering and annotation in a single
computational framework.
Based on our analysis, 326 genes were selected as differentially
expressed and 12 different patterns of gene expression profile were
identified. For example, the expression pattern 1 (Figure 2) shows
a slow and gradual decrease in gene expression whereas in pattern
4 there is a gradual increase in gene expression reaching a peak at
about 5 hours and then reaching a plateau. These patterns are
annotated with a number of functional annotation (Figure 3). In
particular, pattern 1 is enriched with GO groups Ion binding,
Cation transmembrane transporter activity, Transferase activity,
Oxidoriductase activity, Nucleotide binding; GTPase regulator
activity, DNA binding and Protein binding; whereas pattern 4 is
enriched with GO groups Ion binding, Transferase activity,
Nucleotide binding, RNA binding, Receptor activity and Protein
binding. Interestingly pattern 3, showing an initial decrease in
gene expression followed by a variable pattern of increase in gene
expression over time, is enriched with GO group Phosphatase
activity and is anticorrelated with pattern 2, enriched with GO
group Protein serine/threonine kinase activity. Besides generic
annotation as Protein binding or RNA binding, pattern 2 is also
enriched with GO groups Transmembrane transporter activity,
Transferase activity and Receptor activity. All genes in pattern 5
are annotated as Nucleotide binding, all genes in pattern 10 as
DNA binding. More interestingly, all genes in patterns 9, 11 and
12 are annotated in Insulin signaling pathway, with patterns 9 and
11 anticorrelated. 65% of the genes in pattern 8 are also annotated
in Insulin signaling pathway; the remaining genes associated to
pattern 8 are annotated in GO groups Phosphatase activity and
Cation transmembrane transporter activity. Finally, patterns 6 and
7 are enriched with GO group Ion binding; pattern 6 also with
GO group Receptor activity. The identified patterns are followed
rather tightly by the genes in each cluster. Such a consistent
behavior supports our confidence on the reliability of the cluster
average pattern. Moreover the three replicated experiments show
high data reproducibility: the variance calculated across replicates
for the 326 genes selected as differentially expressed has median
value equal to 7% with first and third quartiles equal to 0.03 and
0.15 respectively.
Approximately 20% of the genes that were differentially
expressed were identified as belonging to the insulin signaling
pathway (Figure 4). Of interest, most of the genes were down-
regulated in response to insulin treatment under the present
experimental conditions. The results that demonstrate that IRS-1
mRNA abundance is initially down-regulated (pattern 12) with
insulin treatment is consistent with the recent observation the IRS-
1 mRNA abundance was down-regulated following a three hour
insulin infusion during an in vivo hyperinsulinemic-euglycemic
clamp [30]. It should be noted that after 6 h of treatment the IRS-
1 mRNA abundance returned to baseline, followed by a slight
increase in mRNA abundance above baseline between 6 and 8 h.
However, the present results are in contrast to the recent finding
that genes involved in insulin signaling were largely up-regulated
in response to a three hour insulin infusion during an in vivo
hyperinsulinemic-euglycemic clamp [18]. Moreover, our results
that IRS-2 mRNA abundance is down-regulated (pattern 2) in
response to insulin treatment in vitro under the present experi-
mental conditions is in contrast to modest increase in IRS-2
mRNA abundance in response to a four hour insulin infusion
during an in vivo hyperinsulinemic-euglycemic clamp [31]. In
addition, the angiogenic/anti-apoptotic gene transcripts, VEGF,
FOS, and SRF, were up-regulated in response to the insulin
treatment, which is consistent with the findings of Hansen and
colleagues [25]. Greenhaff and colleagues have recently reported
[32] AKT (PKB) mRNA abundance remains unchanged following
three hours of hyperinsulinemia under four different steady-state
insulin concentrations range from 5 mU/l to ,170 mU/L. The
mRNA (transcripts) expressions in the current study and other
studies represent the net changes related to production and
degradation of mRNA. It is possible that insulin’s primary effect is
translation of the transcripts involved in glucose metabolism. A
higher rate of transcription than translation of these genes would
have resulted in higher transcript levels. In addition, insulin also
stimulates skeletal muscle glucose uptake by the phosphorylation
of specific signaling proteins involved in glucose metabolism in
skeletal muscle [33].
Figure 3. Percentage of genes belonging to insulin signaling pathway (IS) and to 13 different GO groups. Each group is defined as a set
of nodes directly connected in the GO graph and labeled with the most general of these nodes. Enriched GO terms (p-value,0.05) are highlighted
with a star symbol.
doi:10.1371/journal.pone.0032391.g003
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The present results also indicate that insulin treatment in vitro
stimulates gene expression changes that likely promote protein
synthesis. Specifically, insulin treatment resulted in down-regula-
tion of mRNA abundance of TSC2 (pattern 12), which is a known
negative regulator of protein synthesis. Mechanistically, TSC1
(hamartin) forms a complex with TSC2 (tuberin) [TSC1–TSC2
complex], which functions as a critical regulator of protein
synthesis and cell growth [34,35]. Indeed, loss-of-function
mutations in TSC2 have been shown to reduce mTOR and s6k
activity [36]. Moreover, insulin treatment resulted in up-regulation
of mRNA abundance of Rheb (pattern 7), which is known positive
regulator of protein synthesis [37]. Mechanistically, Rheb-GTP
binds directly to the mTOR kinase domain, which in turn
activates mTOR’s catalytic function [30]. Insulin treatment also
likely promotes translational initiation by down-regulating mRNA
abundance of EIFBP1 (pattern 12), while simultaneously up-
regulating mRNA abundance of EIF4E (pattern 4). These findings
are consistent with recent finding reported by Colleta and
colleagues [31] who observed an increased mRNA abundance
for EIF4E following a four hour insulin infusion during an in vivo
Figure 4. Mapping of differentially expressed genes on the insulin signaling pathway. 62 genes (in red) belonging to the insulin signaling
pathway (GenMapp), selected as differentially expressed and associated with significant temporal expression patterns.
doi:10.1371/journal.pone.0032391.g004
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hyperinsulinemic-euglycemic clamp. Furthermore, insulin treat-
ment resulted in up-regulation of mRNA abundance of DNA-
directed RNA polymerase I polypeptides E (pattern 4), B (pattern
4), C (pattern 7) and DNA-directed RNA polymerase II
polypeptide C (pattern 7) [Table S1.10] as well as mRNA
abundance of several RNA binding proteins (patterns 2, 4 and 7)
[Table S1.11].
The current in vitro experiments cannot be directly translated in
to in vivo situation in either human or animals. First, the present
experiments were conducted in differentiated L6 myotubes and
not in fully developed skeletal muscle fibers. Second, the
differentiated L6 myotubes were incubated in normal-glucose
(5 mM glucose) in the presence of relatively high insulin
concentrations (20 nM) in order to elicit maximal effect in an ex-
vivo study. Moreover, the present experiments were conducted in a
serum starved state. Therefore, the changes in mRNA transcripts
both in the treated and control conditions likely also reflect the
effects of progressive serum starvation. The responses may be
different in hyperglycemic conditions with lower or higher insulin
concentrations. Moreover, insulin is known to reduce protein
degradation and amino acid levels [38] Therefore, future in vivo
studies are warranted that examine the effect of hyperinsulinemia
while maintaining both euglycemia and euaminoacidemia.
The present investigation demonstrates a gene array experi-
mental design and methodology for examining temporal changes
in gene expression. Using gene array profiling, we identified 12
different temporal patterns of gene expression in response to eight
hours of insulin treatment in vitro. These results are likely to help
design of in vivo studies to examine the effect of insulin treatment
on the temporal regulation of gene expression related to glucose
uptake in human and animals. Finally, the insulin treatment
affected not only the transcripts involved in glucose metabolism
but also stimulated gene transcripts that would promote protein
synthesis.
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